Lipid-overloaded enlarged adipocytes provoke insulin resistance independent of inflammation

Molecular and Cellular Biology

Volumn 35, Issue 10, 2015, Pages 1686-1699

  Kim, Jong In ^a   Huh, Jin Young ^a   Sohn, Jee Hyung ^a   Choe, Sung Sik ^a   Lee, Yun Sok ^b,d   Lim, Chun Yan ^c   Jo, Ala ^a   Park, Seung Bum ^a   Han, Weiping ^c   Kim, Jae Bum ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c AGENCY FOR SCIENCE   (Singapore)

^d Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FAT DROPLET; GLUCOSE TRANSPORTER 4; INSULIN; LIPID; MONOUNSATURATED FATTY ACID; SATURATED FATTY ACID; CYTOKINE; FAT INTAKE; FATTY ACID; SLC2A4 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE; GENE; GLUCOSE TRANSPORT; INFLAMMATION; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; TOLL LIKE RECEPTOR 4 GENE; 3T3 CELL LINE; ADMINISTRATION AND DOSAGE; ANIMAL; BIOLOGICAL MODEL; CHEMICALLY INDUCED; DRUG EFFECTS; FAT INTAKE; GENETICS; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; MOLECULAR GENETICS;

MUS;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL MEMBRANE; CYTOKINES; DIETARY FATS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, NONESTERIFIED; GLUCOSE TRANSPORTER TYPE 4; IN VITRO TECHNIQUES; INSULIN RESISTANCE; LIPID DROPLETS; MALE; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; OBESITY; TOLL-LIKE RECEPTOR 4;

EID: 84929223982     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01321-14     Document Type: Article

References (59)

1. Kershaw EE, Flier JS. 2004. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556. http://dx.doi.org/10.1210/jc.2004-0395.
2. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. 2003. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112:91-100. http://dx.doi.org/10.1172/JCI17797.
3. Wang QA, Tao C, Gupta RK, Scherer PE. 2013. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med 19:1338-1344. http://dx.doi.org/10.1038/nm.3324.
4. Martinsson A. 1969. Hypertrophy and hyperplasia of human adipose tissue in obesity. Pol Arch Med Wewn 42:481-486.
5. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808. http://dx.doi.org/10.1172/JCI19246.
6. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830. http://dx.doi.org/10.1172/JCI19451.
7. Ceddia RB, Koistinen HA, Zierath JR, Sweeney G. 2002. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 16:1163-1176. http://dx.doi.org/10.1096/fj.02-0158rev.
8. Lumeng CN, Bodzin JL, Saltiel AR. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175-184. http://dx.doi.org/10.1172/JCI29881.
9. Odegaard JI, Chawla A. 2008. Mechanisms of macrophage activation in obesity-induced insulin resistance. Nat Clin Pract Endocrinol Metab 4:619-626. http://dx.doi.org/10.1038/ncpendmet0976.
10. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. 2002. A central role for JNK in obesity and insulin resistance. Nature 420:333-336. http://dx.doi.org/10.1038/nature01137.
11. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE. 2001. Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:1673-1677. http://dx.doi.org/10.1126/science.1061620.
12. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, Shulman GI. 2001. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108:437-446. http://dx.doi.org/10.1172/JCI11559.
13. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M. 2005. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11:191-198. http://dx.doi.org/10.1038/nm1185.
14. Sears DD, Miles PD, Chapman J, Ofrecio JM, Almazan F, Thapar D, Miller YI. 2009. 12/15-lipoxygenase is required for the early onset of high fat dietinduced adipose tissue inflammation and insulin resistance in mice. PLoS One 4:e7250. http://dx.doi.org/10.1371/journal.pone.0007250.
15. Kleemann R, van Erk M, Verschuren L, Van Den Hoek AM, Koek M, Wielinga PY, Jie A, Pellis L, Bobeldijk-Pastorova I, Kelder T, Toet K, Wopereis S, Cnubben N, Evelo C, van Ommen B, Kooistra T. 2010. Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance. PLoS One 5:e8817. http://dx.doi.org/10.1371/journal.pone.0008817.
16. Lee YS, Li P, Huh JY, Hwang IJ, Lu M, Kim JI, Ham M, Talukdar S, Chen A, Lu WJ, Bandyopadhyay GK, Schwendener R, Olefsky J, Kim JB. 2011. Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 60:2474-2483. http://dx.doi.org/10.2337/db11-0194.
17. Wiedemann MS, Wueest S, Grob A, Item F, Schoenle EJ, Konrad D. 2014. Short-term HFD does not alter lipolytic function of adipocytes. Adipocyte 3:115-120. http://dx.doi.org/10.4161/adip.27575.
18. Wiedemann MS, Wueest S, Item F, Schoenle EJ, Konrad D. 2013. Adipose tissue inflammation contributes to short-term high-fat dietinduced hepatic insulin resistance. Am J Physiol Endocrinol Metab 305: E388-E395. http://dx.doi.org/10.1152/ajpendo.00179.2013.
19. Sciacqua A, Marini MA, Hribal ML, Perticone F, Sesti G. 2013. Association of insulin resistance indexes to carotid intima-media thickness. PLoS One 8:e53968. http://dx.doi.org/10.1371/journal.pone.0053968.
20. Dalmas E, Kahn JF, Giral P, Abdennour M, Bouillot JL, Fellahi S, Oppert JM, Clement K, Guerre-Millo M, Poitou C. 2013. Intima-media thickness in severe obesity: links with BMI and metabolic status but not with systemic or adipose tissue inflammation. Diabetes Care 36:3793-3802. http://dx.doi.org/10.2337/dc13-0256.
21. Gao H, Mejhert N, Fretz JA, Arner E, Lorente-Cebrian S, Ehrlund A, Dahlman-Wright K, Gong X, Stromblad S, Douagi I, Laurencikiene J, Dahlman I, Daub CO, Ryden M, Horowitz MC, Arner P. 2014. Early B cell factor 1 regulates adipocyte morphology and lipolysis in white adipose tissue. Cell Metab 19:981-992. http://dx.doi.org/10.1016/j.cmet.2014.03.032.
22. Shoelson SE, Herrero L, Naaz A. 2007. Obesity, inflammation, and insulin resistance. Gastroenterology 132:2169-2180. http://dx.doi.org/10.1053/j.gastro.2007.03.059.
23. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Kadowaki T. 1999. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4:597-609. http://dx.doi.org/10.1016/S1097-2765(00)80210-5.
24. Park J, Lee HY, Cho MH, Park SB. 2007. Development of a cy3-labeled glucose bioprobe and its application in bioimaging and screening for anticancer agents. Angew Chem Int Ed Engl 46:2018-2022. http://dx.doi.org/10.1002/anie.200604364.
25. Brenner RR, Vazza DV, Detomas ME. 1963. Effect of a fat-free diet and of different dietary fatty acids (palmitate, oleate, and linoleate) on the fatty acid composition of fresh-water fish lipids. J Lipid Res 4:341-345.
26. Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS. 2011. The human serum metabolome. PLoS One 6:e16957. http://dx.doi.org/10.1371/journal.pone.0016957.
27. Nguyen MT, Satoh H, Favelyukis S, Babendure JL, Imamura T, Sbodio JI, Zalevsky J, Dahiyat BI, Chi NW, Olefsky JM. 2005. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem 280:35361-35371. http://dx.doi.org/10.1074/jbc. M504611200.
28. Staiger H, Staiger K, Stefan N, Wahl HG, Machicao F, Kellerer M, Haring HU. 2004. Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes 53:3209-3216. http://dx.doi.org/10.2337/diabetes.53.12.3209.
29. Schiller ZA, Schiele NR, Sims JK, Lee K, Kuo CK. 2013. Adipogenesis of adipose-derived stem cells may be regulated via the cytoskeleton at physiological oxygen levels in vitro. Stem Cell Res Ther 4:79. http://dx.doi.org/10.1186/scrt230.
30. Feng T, Szabo E, Dziak E, Opas M. 2010. Cytoskeletal disassembly and cell rounding promotes adipogenesis from ES cells. Stem Cell Rev 6:74-85. http://dx.doi.org/10.1007/s12015-010-9115-8.
31. Stockli J, Fazakerley DJ, James DE. 2011. GLUT4 exocytosis. J Cell Sci 124:4147-4159. http://dx.doi.org/10.1242/jcs.097063.
32. Hong C, Tontonoz P. 2008. Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Curr Opin Genet Dev 18:461-
33. Koh YJ, Park BH, Park JH, Han J, Lee IK, Park JW, Koh GY. 2009. Activation of PPAR gamma induces profound multilocularization of adipocytes in adult mouse white adipose tissues. Exp Mol Med 41:880-895. http://dx.doi.org/10.3858/emm.2009.41.12.094.
34. Wernstedt Asterholm I, Tao C, Morley TS, Wang QA, Delgado-Lopez F, Wang ZV, Scherer PE. 2014. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab 20:103-118. http://dx.doi.org/10.1016/j.cmet.2014.05.005.
35. Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjogren A, Rudemo M, Lystig TC, Carlsson B, Carlsson LM, Lonn M. 2006. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 20:1540-1542. http://dx.doi.org/10.1096/fj.05-5678fje.
36. Bluher M, Wilson-Fritch L, Leszyk J, Laustsen PG, Corvera S, Kahn CR. 2004. Role of insulin action and cell size on protein expression patterns in adipocytes. J Biol Chem 279:31902-31909. http://dx.doi.org/10.1074/jbc.M404570200.
37. Haller H, Leonhardt W, Hanefeld M, Julius U. 1979. Relationship between adipocyte hypertrophy and metabolic disturbances. Endokrinologie 74:63-72.
38. Davidson MB. 1975. Insulin sensitivity of the large human adipocyte in vitro. Diabetes 24:1086-1093. http://dx.doi.org/10.2337/diab.24.12.1086.
39. Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, Yuasa T, Ebina Y, James DE. 2008. IRS1-independent defects define major nodes of insulin resistance. Cell Metab 7:421-433. http://dx.doi.org/10.1016/j.cmet.2008.04.005.
40. Yeop Han C, Kargi AY, Omer M, Chan CK, Wabitsch M, O'Brien KD, Wight TN, Chait A. 2010. Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation. Diabetes 59:386-396. http://dx.doi.org/10.2337/db09-0925.
41. Han CY, Subramanian S, Chan CK, Omer M, Chiba T, Wight TN, Chait A. 2007. Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes 56:2260-2273. http://dx.doi.org/10.2337/db07-0218.
42. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, Mizuarai S, Kotani H, Yamaoka S, Miyake K, Aoe S, Kamei Y, Ogawa Y. 2007. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27:84-91. http://dx.doi.org/10.1161/01.ATV.0000251608.09329.9a.
43. Ajuwon KM, Spurlock ME. 2005. Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes. J Nutr 135:1841-1846.
44. Bradley RL, Fisher FF, Maratos-Flier E. 2008. Dietary fatty acids differentially regulate production of TNF-alpha and IL-10 by murine 3T3-L1 adipocytes. Obesity (Silver Spring) 16:938-944. http://dx.doi.org/10.1038/oby.2008.39.
45. Brozinick JT, Jr, Hawkins ED, Strawbridge AB, Elmendorf JS. 2004. Disruption of cortical actin in skeletal muscle demonstrates an essential role of the cytoskeleton in glucose transporter 4 translocation in insulinsensitive tissues. J Biol Chem 279:40699-40706. http://dx.doi.org/10.1074/jbc. M402697200.
46. Rivero F, Koppel B, Peracino B, Bozzaro S, Siegert F, Weijer CJ, Schleicher M, Albrecht R, Noegel AA. 1996. The role of the cortical cytoskeleton: F-actin crosslinking proteins protect against osmotic stress, ensure cell size, cell shape and motility, and contribute to phagocytosis and development. J Cell Sci 109(Part 11):2679-2691.
47. James DE, Strube M, Mueckler M. 1989. Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 338:83-87. http://dx.doi.org/10.1038/338083a0.
48. Birnbaum MJ. 1989. Identification of a novel gene encoding an insulinresponsive glucose transporter protein. Cell 57:305-315. http://dx.doi.org/10.1016/0092-8674(89)90968-9.
49. James DE, Brown R, Navarro J, Pilch PF. 1988. Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature 333:183-185. http://dx.doi.org/10.1038/333183a0.
50. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, Kahn BB. 2001. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409:729-733. http://dx.doi.org/10.1038/35055575.
51. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB. 1993. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 268: 22243-22246.
52. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol 4:499-511. http://dx.doi.org/10.1038/nri1391.
53. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088. http://dx.doi.org/10.1126/science.282.5396.2085.
54. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025. http://dx.doi.org/10.1172/JCI28898.
55. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, Araujo EP, Vassallo J, Curi R, Velloso LA, Saad MJ. 2007. Loss-of-function mutation in Toll-like receptor 4 prevents dietinduced obesity and insulin resistance. Diabetes 56:1986-1998. http://dx.doi.org/10.2337/db06-1595.
56. Suganami T, Mieda T, Itoh M, Shimoda Y, Kamei Y, Ogawa Y. 2007. Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem Biophys Res Commun 354:45-49. http://dx.doi.org/10.1016/j.bbrc.2006.12.190.
57. Poggi M, Bastelica D, Gual P, Iglesias MA, Gremeaux T, Knauf C, Peiretti F, Verdier M, Juhan-Vague I, Tanti JF, Burcelin R, Alessi MC. 2007. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50:1267-1276. http://dx.doi.org/10.1007/s00125-007-0654-8.
58. Vijay-Kumar M, Aitken JD, Carvalho FA, Ziegler TR, Gewirtz AT, Ganji V. 2011. Loss of function mutation in toll-like receptor-4 does not offer protection against obesity and insulin resistance induced by a diet high in trans fat in mice. J Inflamm (Lond) 8:2. http://dx.doi.org/10.1186/1476-9255-8-2.
59. Choe SS, Shin KC, Ka S, Lee YK, Chun JS, Kim JB. 2014. Macrophage HIF-2alpha ameliorates adipose tissue inflammation and insulin resistance in obesity. Diabetes 63:3359-3371. http://dx.doi.org/10.2337/db13-1965.